)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
PYC Therapeutics
PYC Therapeutics (PYC) investor relations material
PYC Therapeutics Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary24 Feb, 2026
Executive summary
Recent financing has strengthened the balance sheet, providing over $750 million in cash and enabling advancement of four pipeline assets through human efficacy readouts and potentially into late-stage development independently.
Tier 1 specialist and leading global life science investors have joined, aligning incentives and providing strategic industry connections.
The company focuses on RNA therapeutics and disease-modifying therapies for severe genetic diseases with high unmet need, leveraging genetically validated targets and patient-derived models to de-risk development.
Pipeline includes three clinical-stage assets, aiming to present human efficacy data for four indications over the next 24 months.
Multiple near-term human efficacy readouts are expected, with assets positioned in late-stage clinical development.
Financial highlights
Upon closure of the retail entitlement offer, total funds raised will be AUD 600–650 million, resulting in a cash balance exceeding $750 million and a funding runway through 2030.
Strong shareholder register with substantial new investment, including AUD 333.3 million worth of stock allocated to new investors at the same price as the entitlement offer.
Outlook and guidance
All four pipeline assets are expected to deliver human safety and efficacy data within the next 24 months, with key readouts in 2026 and 2027.
All four drug candidates are on track to advance into registrational trials, with clinical proof of concept and NDA submissions as immediate objectives.
The Polycystic Kidney Disease (PKD) program is advancing to repeat dose studies in Q2, with key biomarker and anatomical endpoints ahead.
Phelan-McDermid syndrome program delayed by 12 months due to requirements for juvenile toxicology studies, targeting IND submission in Q1 next year.
Ophthalmology programs (RP11 and ADOA) are awaiting long-term efficacy data and regulatory alignment before phase III initiation.
VP-001 LLVA data vs. natural disease progression
Expected timing for multiple PoCs?
PMS program de-risking for First-In-Human
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
PYC Therapeutics
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
PYC Therapeutics Limited is an Australia-based biotechnology company focused on developing RNA-based therapies to treat genetic diseases. The company specializes in precision medicine, leveraging its RNA therapeutic platform to design and deliver drugs targeting the root causes of genetic disorders. PYC Therapeutics is involved in preclinical and clinical development, with a focus on rare inherited diseases, particularly those affecting vision and the central nervous system. The company is headquartered in Perth, Western Australia, and its shares are listed on the ASX.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage